We are live on ! Find out more
PIIIW icon

P3 Health Partners Warrant

29 hedge funds and large institutions have $26.5M invested in P3 Health Partners Warrant in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more capital inflows, than outflows

Capital inflows: $2.74M | Capital outflows: $2.01M

28% less funds holding

Funds holding: 40 → 29 (-11)

58% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 12

92% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 12

Holders
29
Holders Change
-11
Holders Change %
-27.5%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
12
Closed
12
Calls
$887K
Puts
–
Net Calls
+$887K
Net Calls Change
+$537K

PIIIW Hedge Fund Activity: Q1 2022 in Review

29 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners Warrant (PIIIW) for Q1 2022, worth a combined $26.5M — up 140% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of PIIIW and 1 opened new positions — a net loss of 11 holders — while 12 trimmed existing stakes and 5 added.

The largest buyer was LMR Partners, adding an estimated $1.57M. The largest seller was Ameriprise, exiting entirely with an estimated $519K sold.

  • 29 institutional investors held P3 Health Partners Warrant (PIIIW) as of Q1 2022, down from 40 in Q4 2021.
  • Funds reported $26.5M of P3 Health Partners Warrant stock for Q1 2022, up 140% quarter-over-quarter.
  • 1 fund opened new P3 Health Partners Warrant positions in Q1 2022 and 12 closed out, a net change of -11 holders.
  • The largest P3 Health Partners Warrant buyer in Q1 2022 was LMR Partners, an estimated $1.57M added.
  • The largest P3 Health Partners Warrant seller in Q1 2022 was Ameriprise, an estimated $519K sold.

Based on aggregated 13F filings for Q1 2022.